Decitabine (Dr.Reddy’s Laboratories Inc)
Welcome to the PulseAid listing for the Decitabine drug offered from Dr.Reddy’s Laboratories Inc. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dr.Reddy’s Laboratories Inc |
NON-PROPRIETARY NAME: | Decitabine |
SUBSTANCE NAME: | DECITABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-07-11 |
END MARKETING DATE: | 0000-00-00 |
Decitabine HUMAN PRESCRIPTION DRUG Details:
Item Description | Decitabine from Dr.Reddy’s Laboratories Inc |
LABELER NAME: | Dr.Reddy’s Laboratories Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/50mL) |
START MARKETING DATE: | 2013-07-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43598-348_bf9728a8-848d-9fdc-1647-f11a11b45758 |
PRODUCT NDC: | 43598-348 |
APPLICATION NUMBER: | ANDA203131 |
Other DECITABINE Pharmaceutical Manufacturers / Labelers: